Former CSO, GenomeBC
Brad Popovich is the former Chief Scientific Officer at Genome British Columbia in Vancouver BC (2011-present). His involvement in the organization spans many years; Brad sat on the board of directors from 2006-2011. He also acted as chair for the Science Committee at Genome British Columbia from 2008-2010. Outside his present role at Genome BC, Brad serves as Chairman, Genetic Information Management Systems, and Director, Centre for Drug Research and Development Ventures (CVI) and Centre for Drug Research and Development (CDRD).
Brad was the President and Chief Executive Officer of Sirius Genomics from 2006-2009 and was the Vice President of Operations at Xenon Pharmaceuticals (2001-2005). Previously, he was the Founder and Director to the Molecular Diagnostics Laboratory at Oregon Health Sciences University where he was also the Director of Graduate Education and the Executive Director, Genetic Service Laboratories at the University Hospital (1992-2001). Brad was previously the Founder and Director of the DNA Diagnostic Laboratory at Children’s Hospital San Diego / University of California San Diego (1989-1992).
Previously Brad served as a Director for: Sirius Genomics (2006-2012); DNA Direct (2005-2010); Tm Bioscience (2003-2006); the American College of Medical Genetics (Director and VP Laboratory Genetics 1999-2005); and the American College of Medical Genetics Foundation (1999-2005). He additionally Chaired the Oregon Genetic Privacy Advisory Committee (1995-2001) and was a founding member of the Oregon DNA Forensic Experts Panel (1993-2001).
Brad’s genetic training is in genetic counselling (MS, Sarah Lawrence College) biochemical genetics (MSc, McGill University), molecular genetics (PhD, McGill University), and postdoctoral training / clinical fellowship (University of Wisconsin, and University of North Carolina (laboratory of Nobel Laureate Oliver Smithies). He became board certified in clinical molecular genetics in 1993 by the American Board of Medical Specialists and the American Board of Medical Genetics.